Luxna Biotech Co., Ltd.

  • EN
  • JP

Luxna Biotech Co., Ltd.

  • About
  • Oligonucleotide Therapeutics
  • Technology
  • Business Structure
  • News
  • Open Positions
  • Access
  • Contact
ルクサナバイオテク株式会社
  • About
  • Oligonucleotide Therapeutics
  • Technology
  • Business Structure
  • News
  • Open Positions
  • Access
  • Contact

News

  1. HOME
  2. News

Notice of Option Agreement with Servier

  • 2023/12/20
  • Notice
Read

We are selected for “KSII Zebra” by the Kansai Innovation Initiative (KSII).

  • 2023/12/15
  • Notice
Read

Notification of Formulation of General Business Owner Action Plans

  • 2023/11/30
  • Notice
Read

Our President CEO, Mr. Hideaki Sato, will participate in “Global Finance & Innovation Forum in Osaka 2023” as a speaker.

  • 2023/11/21
  • Event
Read

We will participate in the BIO Europe in, Munich, Germany.

  • 2023/10/02
  • Event
Read

We will be exhibiting at the SME Support, JAPAN Exhibition Booth at Bio Japan 2023.

  • 2023/09/28
  • Event
Read

We will be exhibiting at EU-Japan Biotech & Pharma Partnering Conference.

  • 2023/09/27
  • Event
Read

We are selected as finalists for “Citeline Pharma Intelligence Awards Japan 2023”.

  • 2023/09/26
  • Notice
Read

Notification of Eligible Invoicing Business Registration Number

  • 2023/09/20
  • Notice
Read

Our President & CEO, Mr. Hideaki Sato, will participate in “The 29th Annual Meeting of Japan Society of Gene and Cell Therapy” as a speaker.

  • 2023/08/28
  • Event
Read
  • Prev
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Luxna Biotech Co., Ltd.

  • C907 9F Bldg. C, Techno-Alliance Complex, 2-8 Yamadaoka, Suita, Osaka 565-0871 JAPAN
  • TEL: +81(0)6-6170-1228
  • FAX: +81(0)6-6170-2207
  • MAIL: info@luxnabiotech.co.jp
  • About
  • Oligonucleotide Therapeutics
  • Technology
  • Business Structure
  • News
  • Open Positions
  • Company Overview
  • Contact
  • Animal Experiments Policy
  • Privacy Protection Policy
  • Site Map

Copyright © 2018 Luxna Biotech Co., Ltd. All Rights Reserved.